Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Metabolic Messengers: glucagon-like peptide 1
Fiona M. Gribble, Frank Reimann
Nature Metabolism (2021) Vol. 3, Iss. 2, pp. 142-148
Closed Access | Times Cited: 143

Showing 1-25 of 143 citing articles:

Microbial-host-isozyme analyses reveal microbial DPP4 as a potential antidiabetic target
Kai Wang, Zhiwei Zhang, Jing Hang, et al.
Science (2023) Vol. 381, Iss. 6657
Open Access | Times Cited: 79
GLP-1a: Going beyond Traditional Use
Lucas Fornari Laurindo, Sandra Maria Barbalho, Élen Landgraf Guiguer, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 2, pp. 739-739
Open Access | Times Cited: 71
Gut hormone-based pharmacology: novel formulations and future possibilities for metabolic disease therapy
Matthias H. Tschöp, Rubén Nogueiras, Bo Åhrén
Diabetologia (2023) Vol. 66, Iss. 10, pp. 1796-1808
Open Access | Times Cited: 51
Advances in Research on Type 2 Diabetes Mellitus Targets and Therapeutic Agents
Jingqian Su, Yingsheng Luo, Shan Hu, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 17, pp. 13381-13381
Open Access | Times Cited: 46
Metformin-based nanomedicines for reprogramming tumor immune microenvironment
Jieyu Liu, Xiaoling Li, Yinggang Li, et al.
Theranostics (2024) Vol. 15, Iss. 3, pp. 993-1016
Closed Access | Times Cited: 34
Short‐chain fatty acids: bridges between diet, gut microbiota, and health
Ling‐Yun Wang, Lihong He, Lijun Xu, et al.
Journal of Gastroenterology and Hepatology (2024) Vol. 39, Iss. 9, pp. 1728-1736
Open Access | Times Cited: 20
GLP-1 and the Neurobiology of Eating Control: Recent Advances
Lauren A. Jones, Daniel I. Brierley
Endocrinology (2025)
Open Access | Times Cited: 2
Dipeptidyl Peptidase (DPP)-IV Inhibitors with Antioxidant Potential Isolated from Natural Sources: A Novel Approach for the Management of Diabetes
Anand-Krishna Singh, Dhananjay Yadav, Neha Sharma, et al.
Pharmaceuticals (2021) Vol. 14, Iss. 6, pp. 586-586
Open Access | Times Cited: 61
GLP-1 regulates exercise endurance and skeletal muscle remodeling via GLP-1R/AMPK pathway
Luting Wu, Min Zhou, Tianyou Li, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Cell Research (2022) Vol. 1869, Iss. 9, pp. 119300-119300
Open Access | Times Cited: 44
Envisioning how to advance the MASH field
Alina M. Allen, Zobair M. Younossi, Anna Mae Diehl, et al.
Nature Reviews Gastroenterology & Hepatology (2024)
Closed Access | Times Cited: 13
Sympathetic nerve-enteroendocrine L cell communication modulates GLP-1 release, brain glucose utilization, and cognitive function
Wenran Ren, Jianhui Chen, Wenjing Wang, et al.
Neuron (2024) Vol. 112, Iss. 6, pp. 972-990.e8
Open Access | Times Cited: 10
Glucagon-like peptide-1 receptor agonists rescued diabetic vascular endothelial damage through suppression of aberrant STING signaling
Xuemin He, Siying Wen, Xixiang Tang, et al.
Acta Pharmaceutica Sinica B (2024) Vol. 14, Iss. 6, pp. 2613-2630
Open Access | Times Cited: 10
Glucagon-like peptide-1 (GLP-1) receptor agonists for headache and pain disorders: a systematic review
Wael Halloum, Yousef Al Dughem, Dagmar Beier, et al.
The Journal of Headache and Pain (2024) Vol. 25, Iss. 1
Open Access | Times Cited: 8
Focus on Glucagon-like Peptide-1 Target: Drugs Approved or Designed to Treat Obesity
Jiahua Zhang, Jintao Wei, Weiwen Lai, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 4, pp. 1651-1651
Open Access | Times Cited: 1
Glucagon‐like peptide‐1 (GLP‐1) signalling in the brain: From neural circuits and metabolism to therapeutics
Anita Kabahizi, Briana Wallace, Linh Lieu, et al.
British Journal of Pharmacology (2021) Vol. 179, Iss. 4, pp. 600-624
Open Access | Times Cited: 43
Microbial Tryptophan Metabolism Tunes Host Immunity, Metabolism, and Extraintestinal Disorders
Moyan Liu, Max Nieuwdorp, Willem M. de Vos, et al.
Metabolites (2022) Vol. 12, Iss. 9, pp. 834-834
Open Access | Times Cited: 32
Bile acids, gut microbiota and metabolic surgery
Jui Tu, Yangmeng Wang, Lihua Jin, et al.
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 28
Red ginseng extracts ameliorate high-fat diet-induced obesity and insulin resistance by activating the intestinal TGR5-mediated bile acids signaling pathway
Wei Li, Tongxi Zhuang, Zixuan Wang, et al.
Phytomedicine (2023) Vol. 119, pp. 154982-154982
Closed Access | Times Cited: 22
The Mechanism of the Gut-Brain Axis in Regulating Food Intake
Shouren Li, Mengqi Liu, Shixi Cao, et al.
Nutrients (2023) Vol. 15, Iss. 17, pp. 3728-3728
Open Access | Times Cited: 19
GLP-1 metabolite GLP-1(9–36) is a systemic inhibitor of mouse and human pancreatic islet glucagon secretion
Nikhil R. Gandasi, Rui Gao, Lakshmi Kothegala, et al.
Diabetologia (2023) Vol. 67, Iss. 3, pp. 528-546
Open Access | Times Cited: 18
Diabetes: a review of its pathophysiology, and advanced methods of mitigation
Sarika Gupta, Nitin Sharma, Sandeep Arora, et al.
Current Medical Research and Opinion (2024) Vol. 40, Iss. 5, pp. 773-780
Closed Access | Times Cited: 8
Reappraising the role of the vagus nerve in GLP‐1‐mediated regulation of eating
Daniel I. Brierley, Guillaume de Lartigue
British Journal of Pharmacology (2021) Vol. 179, Iss. 4, pp. 584-599
Open Access | Times Cited: 36
Theasinensin A attenuated diabetic development by restoring glucose homeostasis, improving hepatic steatosis and modulating gut microbiota in high-fat-diet/streptozotocin-induced diabetic mice
Weiqi Xu, Yujie Huang, Wangting Zhou, et al.
Food Science and Human Wellness (2023) Vol. 12, Iss. 6, pp. 2073-2086
Open Access | Times Cited: 15
Potential preventive properties of GLP-1 receptor agonists against prostate cancer: a nationwide cohort study
Charlotte Skriver, Søren Friis, Lotte Bjerre Knudsen, et al.
Diabetologia (2023) Vol. 66, Iss. 11, pp. 2007-2016
Closed Access | Times Cited: 15
Vancomycin relieves tacrolimus-induced hyperglycemia by eliminating gut bacterial beta-glucuronidase enzyme activity
Peixia Li, Rui Zhang, Jinping Zhou, et al.
Gut Microbes (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 5
Page 1 - Next Page

Scroll to top